Wynnewood, PA (PRWEB) October 13, 2010
Olfactory Biosciences Corp, (OTC Pink Sheets: OLFC) announced today that NOXO QuitSmoking™is available in an nasal inhaler for an introductory price of $ 19.95 (regular $ 29.95)
The new Noxo QuitSmoking™ stops the body’s craving for nicotine and the urge to smoke by sending scent molecules directly to the brain's "central command" or craving controller thereby helping one to quit smoking.
Dr. Ruth Pinney, Director and VP Research noted, "We finally have a natural product that really works and eliminates the need to smoke when inhaled from our new NOXO QuitSmoking™ olfactory nasal inhaler."
Noxo QuitSmoking™ nasal inhaler contains a special proprietary formulation of Phytonutrients and Phytochemicals taken from plants, flowers, roots and seeds. The company uses NOBEL Prize winning science related to discoveries of odorant receptors in the nose and the organization of the olfactory system.
About Olfactory Biosciences Corp
Olfactory Biosciences Corp.’s NOXO division is focused to develop a variety of products targeting Olfactory Receptors for the desired effect. These alternative medicine wellness products may modify behavior or provide relief to common health problems such as smoking cessation or weight control, as examples. The company has taken NOBEL Prize science related to discoveries of odorant receptors in the nose and the organization of the olfactory system, and has developed unique wellness products that are affordable and made from all natural ingredients. Olfactory Biosciences Corp. offers the most advanced and innovative wellness products with the potential to change the way we approach wellness issues today. Olfactory Biosciences Corp’s unique advantages will make NOXO products the most sought-after wellness products in the alternative medicine market, creating a growth rate ten times higher than most in the this growing category. Consumers concerned about their health are looking for alternatives to replace conventional, over-the-counter consumer medical products. We provide natural wellness products that are both effective and affordable.
Investor & Media Relations:
Safe Harbor for Public Companies
Statements contained in this release that are not strictly historical are "forward-looking statements." Such forward-looking statements are sometimes identified by words such as "intends," "anticipates," "believes," "expects," and "hopes." The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include, but are not limited to, demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders. Olfactory Biosciences Corp., "The Company" currently does not file periodic filings with the Securities and Exchange Commission but will publish financials on the Olfactory Biosciences Corp. website as they become available.
Olfactory Biosciences Corp., Inc
333 E. Lancaster Ave.
Wynnewood, PA 19096